Background: Accumulating evidence implicates diet quality in childhood as playing a significant role in adult cardiometabolic health. Polyunsaturated fatty acids (PUFAs) of the n-6 (ω-6) and n-3 (ω-3) series contribute unique protective effects against cardiometabolic disease. As such, the ratio between n-6 and n-3 PUFAs is a dietary metric of interest in the early life span, although an optimum intake ratio has yet to be determined.

Objective: This cross-sectional study assesses relations between the ratio of total n-6:n-3 PUFA intake and cardiometabolic risk factors in a racially diverse sample of children ( = 191) from the Admixture Mapping of Ethnic and Racial Insulin Complex Outcomes (AMERICO) study.

Methods: Outcome measures included waist circumference, lipid concentrations, fasting glucose, and two 24-h dietary recalls from boys and girls aged 7-12 y who self-reported as European American ( = 81), African American ( = 55), or Hispanic American ( = 55). Linear regression analyses were used to assess associations between predictors of interest and outcomes after adjusting for covariates.

Results: PUFA intake reflected in the n-6:n-3 ratio was inversely associated with concentrations of total and LDL cholesterol [β ± SE: -0.359 ± 0.107 (= 0.001) and -0.189 ± 0.069 (= 0.007), respectively]. Exploratory analyses showed that the intake of total n-6 PUFAs was not significantly predictive of any cardiometabolic risk factor assessed, whereas total n-3 PUFA intake was positively associated with concentrations of HDL cholesterol (β ± SE: 0.114 ± 0.042; = 0.007).

Conclusions: Results suggest that the effect of n-6 and n-3 PUFA intake reflected in the ratio may be largely driven by n-3 PUFAs in reducing 2 lipid cardiometabolic risk factors among this multiethnic cohort of children. Until an ideal intake ratio is determined, nutritional counseling should focus on meeting recommended levels of both n-3 and n-6 PUFAs in order to establish beneficial childhood dietary patterns that may positively influence adult cardiometabolic health.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998369PMC
http://dx.doi.org/10.1093/cdn/nzy014DOI Listing

Publication Analysis

Top Keywords

cardiometabolic risk
16
pufa intake
16
risk factors
12
intake
8
factors racially
8
racially diverse
8
diverse sample
8
sample children
8
adult cardiometabolic
8
cardiometabolic health
8

Similar Publications

Steatotic liver disease is prevalent among people with hepatitis C virus (HCV). The new definition of metabolic dysfunction-associated steatotic liver disease (MASLD) emphasises the metabolic drivers of steatosis and recognises its frequent coexistence with other chronic liver diseases, including HCV. We aimed to evaluate the association of coexisting MASLD and HCV with liver fibrosis.

View Article and Find Full Text PDF

Background: The differential impact of serum lipids and their targets for lipid modification on cardiometabolic disease risk is debated. This study used Mendelian randomization to investigate the causal relationships and underlying mechanisms.

Methods: Genetic variants related to lipid profiles and targets for lipid modification were sourced from the Global Lipids Genetics Consortium.

View Article and Find Full Text PDF

Background And Aims: Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) is reversible at early stages, making early identification of high-risk individuals clinically valuable. Previously, we demonstrated that patient-derived induced pluripotent stem cells (iPSCs) harboring MASLD DNA risk variants exhibit greater oleate-induced intracellular lipid accumulation than those without these variants. This study aimed to develop an iPSC-based MASLD risk predictor using functional lipid accumulation assessments.

View Article and Find Full Text PDF

Background: Clonal hematopoiesis of indeterminate potential (CHIP) is the age-related presence of expanded somatic clones secondary to leukemogenic driver mutations and is associated with cardiovascular (CV) disease and mortality. We sought to evaluate relationships between CHIP with cardiometabolic diseases and incident outcomes in high-risk individuals.

Methods: CHIP genotyping was performed in 8469 individuals referred for cardiac catheterization at Duke University (CATHGEN study) to identify variants present at a variant allele fraction (VAF) ≥2%.

View Article and Find Full Text PDF

At the Texas Heart Institute's 2024 Cardiometabolic Syndrome Conference, held on August 23, 2024, experts from diverse academic fields spoke about novel initiatives for addressing the worsening projections for cardiometabolic syndrome. Four major areas in which innovation is ongoing were highlighted: technology, policy, population health, and lifestyle and behavioral modification. This article presents a brief contextualization, summary, and analysis of the novel initiatives being implemented in each of these 4 areas to address cardiometabolic syndrome.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!